$DECK

This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Citius Pharmaceuticals (NASDAQ:CTXR), Citius Oncology (NASDAQ:CTOR)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Ashley Owens downgraded the rating for Deckers Outdoor Corporation DECK from ...

Original reporting
Benzinga · Avi Kapoor
Published May 23, 2025, 3:42 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 23, 2025, 4:01 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
This Deckers Outdoor Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Citius Pharmaceuticals (NASDAQ:CTXR), Citius Oncology (NASDAQ:CTOR) — source image
Decision brief

The 30-second read

$DECKNeutralLow
01

Why it matters

The downgrade has led to some sector-wide caution, but limited immediate impact on related stocks.

02

Market read

The news primarily affects the retail and pharmaceutical sectors, with limited broader market implications.

03

What to watch

Broader economic indicators and company-specific fundamentals could offset negative sentiment; sector resilience should be considered.

Timing: short-term

Background

Recent analyst downgrade of Deckers Outdoor Corporation by Keybanc's Ashley Owens, leading to a cautious outlook.

Company-level read

Ticker impact

$DECKNeutralMedium confidence
Context

Low relevance due to recent analyst downgrade and limited impact on current price.

Expected impact

Minimal to no significant price movement expected in the short term.

Evidence & confidence

The analyst downgrade is specific and recent, but the low relevance score and lack of broader negative sentiment suggest limited impact.

$CTORBullishMedium confidence
Context

Moderate relevance; analyst sentiment is somewhat bullish, but the downgrade of Deckers may influence sector sentiment.

Expected impact

Potential for slight positive movement, but overall limited due to sector-specific factors.

Evidence & confidence

The positive sentiment and relevance score suggest some upward potential, but sector and company-specific factors limit magnitude.

$CTXRBullishMedium confidence
Context

Moderate relevance; similar to CTXR above, with somewhat bullish sentiment.

Expected impact

Possible minor upward movement; however, sector-specific factors may cap gains.

Evidence & confidence

The sentiment indicates potential for slight gains, but overall impact remains limited.

Market effects

Limited sector impact; the news primarily affects consumer discretionary and specialty retail sectors.

Negligible; the news is focused on US-listed companies with limited regional influence.

Low; the news does not have significant global market implications.

Counterpoint

The analyst downgrade may be an overreaction; long-term investors could view this as a buying opportunity if fundamentals remain strong.

Key entities

  • Deckers Outdoor Corporation

    A manufacturer and retailer of footwear and apparel.

  • Citius Pharmaceuticals

    A specialty pharmaceutical company.

  • Citius Oncology

    A biopharmaceutical company focusing on cancer treatments.

  • Radian Group

    A provider of mortgage insurance and real estate services.

  • Reinsurance Group of America

    A global reinsurance company.

Related articles

$DECKMed

Adidas, VF Corp and Deckers Get Checked

Adidas reported Q2 2026 results: revenue €6.74B (record) and operating profit €574M vs €615–€623M estimates. Shares fell about 17% Thursday and were down 5.7% YTD by Friday. Adidas lifted currency-adjusted revenue growth guidance to 9%–10% but kept profit target near €2.3B. VF Corp Q1 2027 revenue was $1.67B; adjusted loss was $0.27 vs $0.22 expected; shares dropped 17.4%. Vans revenue fell to $459.8M (-9% currency-neutral).

$DECKMedAI 8/10

Deckers Brands hits historic $1bn Q1 sales driven by HOKA, UGG

Deckers Brands reported Q1 FY27 net sales of $1.02bn, up 5.7% from $964.5m a year earlier, with HOKA sales up 7.7% to $703.5m and UGG up 4.9% to $278m. Gross margin rose to 56.4%. Operating income fell to $155.3m. CEO cited strong demand and channel growth. Full-year sales outlook kept at $5.86bn-$5.91bn.

$DECKMed

Deckers Outdoor (DECK) Is Down 9.8% After Record First Billion-Dollar Quarter And Higher EPS Guidance

Deckers Outdoor (DECK) reported fiscal Q1 2027 results with record net sales of US$1,019.53 million and net income of US$129.97 million. The company slightly lifted full-year EPS guidance and targets net sales of US$5.86 billion to US$5.91 billion with operating margins just above 21.5%. It plans to use about 80% of projected free cash flow for share repurchases.

$DECKMed

These Analysts Slash Their Forecasts On Deckers Outdoor Following Q1 Results - Deckers Outdoor (NYSE:DECK

Deckers Outdoor (NYSE:DECK) reported Q1 earnings of 94 cents per share, above the 87 cents consensus, and revenue of $1.02 billion versus $1.018 billion expected, according to Benzinga Pro. CEO Stefano Caroti said the company surpassed $1 billion in quarterly revenue for the first time. Shares were down 2.4% premarket to $93.91. Analysts lowered DECK price targets at Baird and Needham.

$DECKMed

HOKA Q1 revenue $703.5m running competition Nike On

Deckers Brands reported Q1 FY2027 results. HOKA revenue rose 7.7% to $703.5m, with DTC up 17% and wholesale up 3%. Gross margin rose 60 bps to 56.4%, while operating income fell 6.0% to $155.3m. Deckers raised FY EPS guidance to $7.35–$7.50 and expects low double-digit HOKA growth, citing reorders and tariff impacts.